The Pseudomonas Genome Database collaborates with an international panel of expert Pseudomonas researchers to provide high quality updates to the PAO1 genome annotation and make cutting edge genome analysis data available

Search Gene Annotations by Name

Exact Name Name Contains
Choose a specific strain (optional)
OR choose a species (optional)
Complete genomes only
Include draft genomes

Database Statistics

Complete Genomes 215
Draft Genomes 3133
Manually-curated annotation updates 3443
Curated GO terms 4381

Latest News

May 2, 2018
Fix introduced for error occurring when advanced searches attempt to filter results to only include drug targets.
December 18, 2017
Pseudomonas Genome Database version 17.2 released with focus on updating names for Type VI secretion system genes in PA14 and recently described ncRNAs.
Updated InterPro motif predictions based on InterProScan v5.25-64.0. Coverage expanded to include proteins from draft genomes.
Updated computationally-predicted GO term annotations based on InterProScan v5.25-64.0. Coverage also expanded to include proteins from draft genomes.
New manually annotated GO term annotations and transfer to identical proteins in other strains (indicated in evidence section).
New entries added to our related links page for various P. aeruginosa reference collections at Public Health England.
September 11, 2017
Fixed broken pathway download link that was always returning results for PAO1.
August 4, 2017
Fixed bug where some columns were missing from downloaded strain data files.
July 7, 2017
Maximum number of hits returned by DNA motif search tool has been increased from 2000 to 5000. Contact us by email for assistance with queries returning more than 5000 hits so that we can help you directly.

Strains and Isolates in the Database

Submit an annotation update

We welcome all suggested updates to Pseudomonas annotations and no registration is required!


PseudoCAP was the first wholly Internet-based and community-based genome annotation project for analysis of a genome of a free-living organism.

Current and past funding

Funding for this work is gratefully provided by Cystic Fibrosis Foundation Therapeutics Inc., a non-profit drug discovery and development affiliate of the Cystic Fibrosis Foundation.